William Mack & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Buy
+1,468
New +$342K 0.13% 67
2026
Q1
Sell
-1,463
Closed -$303K 82
2025
Q4
$303K Buy
1,463
+200
+16% +$39.5K 0.14% 60
2025
Q3
$234K Buy
+1,263
New +$216K 0.13% 74
2025
Q2
Sell
-1,263
Closed -$209K 81
2025
Q1
$209K Buy
+1,263
New +$198K 0.18% 67

Other funds holding JNJ

William Mack & Associates's JNJ Position: Q2 2026 in Review

William Mack & Associates opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,468 shares worth $373K. The stake represents 0.13% of the portfolio and ranks #67 among its holdings. This is a return to the name: William Mack & Associates previously reported a position in JNJ as recently as Q4 2025.

William Mack & Associates first reported a position in JNJ in Q1 2025 and has held it in 4 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • William Mack & Associates held 1,468 shares of Johnson & Johnson worth $373K as of Q2 2026.
  • Johnson & Johnson was a new William Mack & Associates position in Q2 2026.
  • Johnson & Johnson made up 0.13% of William Mack & Associates's portfolio in Q2 2026, its #67 holding.
  • William Mack & Associates first reported a position in Johnson & Johnson in Q1 2025 and has held it in 4 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on William Mack & Associates's 13F filing for Q2 2026, filed 10 Jul 2026.